https://www.selleckchem.com/pr....oducts/lomerizine-hc
39 ± 0.19 vs. 0.33 ± 0.10, = 0.055) before and after commencing NHFOV, respectively. The use of NHFOV is feasible as a prophylactic or rescue mode of NIV following extubation and was associated with decrease in the number of apneas without significant changes in PCO or oxygen requirements. A well-designed randomized control trial is needed to determine the indications, clinical outcomes, and safety of this treatment modality. · NHFOV is a new and evolving mode of noninvasive ventilation.. · The use of NHFOV is feasible as a pro
Like
Comment
Share
